HomeCancerTalkCategories

Category - Cancer Research

PIVOT Prostate Cancer Study Should Empower Men to Make Informed Decisions
Thursday, July 19, 2012 - 10:14am
James L. Mohler, MD
Associate Director, Chair of the Department of Urology and Senior Vice President for Translational Research, RPCI

An important study was published in the New England Journal of Medicine (NEJM) that addresses the use of the prostate-specific antigen test, or PSA test, for early detection and the challenges regarding proper early detection and early treatment of prostate cancer in the PSA era.

Read more
The Evolution of a Promising Cancer Drug - Nine Years in the Making
Thursday, June 7, 2012 - 3:48pm
Andrei Gudkov, PHD, DSCi
Senior Vice President of Basic Science and The Garman Family Chair in Cell Stress Biology

Cancer treatment, as many patients can attest, can cause unwelcome side effects. One of the major focuses of research undertaken by our Cell Stress Biology Department at Roswell Park is to find ways to reduce these side effects and improve the quality of life for our patients. 

Read more
Improving Chemotherapy Response Rates for Melanoma Patients: Case Study Provides Possible Clue
Sunday, May 6, 2012 - 8:54pm
Nikhil Khushalani, MD
Section Chief, Soft Tissue and Melanoma & Director, IL-2 Program, Department of Medicine

Over the last year, we have made great progress in melanoma research. This research has provided us with a better understanding of this deadly disease and has also led to new treatments.

Read more
The Role of Flow Cytometry in Your Cancer Care
Tuesday, February 28, 2012 - 9:48am
Paul Wallace, PhD
Director, Flow and Image Cytometry

As a cancer patient, you may never see a flow cytometer at Roswell Park, but, behind the scenes, this analytical tool plays a vital role in the diagnosis, classification and management of many cancers. I explain a bit more about how flow cytometry may be used in your cancer care in the video and post below.

Read more
Is Avastin a New Treatment Option for Advanced Ovarian Cancer?
Tuesday, February 14, 2012 - 3:24pm
Mark Brady, PhD
Gynecologic Oncology Group (GOG) Statistical and Data Center

By studying the effects of bevacizumab (brand name AvastinTM), a drug currently FDA-approved for use in the treatment of several other cancers, a research team led by the Gynecologic Oncology Group (GOG)  has laid the groundwork for a possible new treatment option for women with advanced ovarian cancer—a treatment option that may increase the time women live without their disease worsening.

Read more
Good Day Sunshine? Vitamin D and Cancer
Monday, February 6, 2012 - 8:00am
See video

Can "the sunshine vitamin" play a role in preventing and treating cancer? Find out what Roswell Park Cancer Institute scientists and clinicians are learning about the inspiring potential of vitamin D for the future of cancer treatment. Featuring an interview with graduate student Sarah Mazzilli and Pamela Hershberger, PhD of Roswell Park's Department of Pharmacology and Therapeutics.

Read more